A Phase I , Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of EGT0001474 In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 18 Jul 2011
At a glance
- Drugs Bexagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Theracos
- 13 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jun 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Mar 2009 New trial record